Leucocytosis Predicts Survival in Metastatic Non Small Cell Lung Carcinoma Patients—A Retrospective Review of a Single Institution Data
- 1 Departement of Medical Oncology, Hassan II University Hospital, Fez, Morocco
- 2 Departement of Medical Oncology, Hassan II University Hospital, Fez, Morocco
- 3 Laboratory of Epidemiology and Biostatistics, Faculty of Medicine of Fez, Fez, Morocco
- 4 Departement of Medical Oncology, Hassan II University Hospital, Fez, Morocco
- 5 Departement of Medical Oncology, Hassan II University Hospital, Fez, Morocco
- 6 Laboratory of Epidemiology and Biostatistics, Faculty of Medicine of Fez, Fez, Morocco
- 7 Departement of Medical Oncology, Hassan II University Hospital, Fez, Morocco
Abstract
Background: Tumor-related leukocytosis is a paraneoplastic syndrome that is encountered occasionally in the clinical course of patients with lung carcinoma. The aim of this study is to evaluate the prognostic significance of leucocytosis in patients with metastatic non small cell lung carcinoma. Methods: We retrospectively reviewed 205 cases of metastatic non small cell lung carcinoma diagnosed between January 2007 and December 2012 at the department of medical oncology, Hassan II University Hospital of Fez, Morocco. Clinical and laboratory data were collected including white blood cells at baseline. Leucocytosis was studied in relation to overall survival and progression free survival. Results: The frequency of leucocytosis was of 57.5%. Patients with leucocytosis had shorter overall survival (OS, p = 0.015 ) and disease-free survival (DFS, p < 0.0001) than those without leucocyto sis. In multivariable analysis, patients with leucocytosis had a significantly greater risk of death and recurrence than those without leucocytosis. Conclusion: Leucocytosis was valuable for predicting the prognosis of patients with metastatic non small cell lung carcinoma.
- Siegel, R., Naishadham, D. and Jemal, A. (2013) Cancer Statistics, 2013. CA: A Cancer Journal for Clinicians, 63, 11-30. https://doi.org/10.3322/caac.21166
- Slungaard, A., Ascensao, J., Zanjani, E. and Jacob, H.S. (1983) Pulmonary Carcinoma with Eosinophilia. The New England Journal of Medicine, 309, 778-781. https://doi.org/10.1056/NEJM198309293091307
- Ascensao, J.L., Oken, M.M., Ewing, S.L., Goldberg, R.J. and Kaplan, M.E. (1987) Leukocytosis and Large Cell Lung Cancer. A Frequent Association. Cancer, 60, 903-905. https://doi.org/10.1002/1097-0142(19870815)60:4 3.0.CO;2-6
- Asano, S., Urabe, A., Okabe, T., Sato, N., Kondo, Y., Ueyama, Y., et al. (1977) Demonstration of Granulopoietic Factors in the Plasma of Nude Mice Transplanted with a Human Lung Cancer and in the Tumor Tissue. Blood, 49, 845-852.
- Deng, Q., Yang, H., Zhang, X., Chen, H., Qiu, Y., Wen, D., Xiong, X., Wang, W. and He, J. (2010) Correlation between Pre-Treatment Anemia and Prognosis in Non-Small Cell Lung Cancer Patients. Zhongguo Fei Ai Za Zhi, 13, 722-726.
- Maione, P., Rossi, A., Di Maio, M. and Gridelli, C. (2009) Tumor-Related Leucocytosis and Chemotherapy-Induced Neutropenia: Linked or Independent Prognostic Factors for Advanced Non-Small Cell Lung Cancer? Lung Cancer, 66, 8-14. https://doi.org/10.1016/j.lungcan.2009.02.022
- Brundage, M.D., Davies, D. and Mackillop, W.J. (2002) Prognostic Factors in Non-Small Cell Lung Cancer: A Decade of Progress. Chest, 122, 1037-1057. https://doi.org/10.1378/chest.122.3.1037
- Donnem, T., Bremnes, R.M., Busund, L.T., et al. (2012) Gene Expression Assays as Prognostic and Predictive Markers in Early Stage Non-Small Cell Lung Cancer. Journal of Thoracic Disease, 4, 212-213.
- Mckee Jr., L.C. (1985) Excess Leukocytosis (Leukemoid Reaction) Associated with Malignant Diseases. The Southern Medical Journal, 78, 1475-1482. https://doi.org/10.1097/00007611-198512000-00018
- Kasuga, I., Makino, S., Kiyokawa, H., et al. (2001) Tumor-Related Leukocytosis Is Linked with Poor Prognosis in Patients with Lung Carcinoma. Cancer, 92, 2399-2405. https://doi.org/10.1002/1097-0142(20011101)92:9 3.0.CO;2-W
- Ferrigno, D. and Buccheri, G. (2003) Hematologic Counts and Clinical Correlates in 1201 Newly Diagnosed Lung Cancer Patients. Monaldi Archives for Chest Disease, 59, 193-198.
- Mandrekar, S.J., Schild, S.E., Hillman, S.L., et al. (2006) A Prognostic Model for Advanced Stage Nonsmall Cell Lung Cancer. Pooled Analysis of North Central Cancer Treatment Group Trials. Cancer, 107, 781-792. https://doi.org/10.1002/cncr.22049